Mr. Jean-Luc Bélingard is a Chairman-Supervisory Board at Biolog-id SAS, an Independent Non-Executive Director at Lupin Ltd., an Independent Director at Laboratory Corp. of America Holdings, a Member-CEO Roundtable at Bill & Melinda Gates Foundation Trust and a Vice President at Institut Mérieux SA. He is on the Board of Directors at Lupin Ltd., Transgene SA, Laboratoire Pierre Fabre Oncologie, bioMérieux SA, Pierre Fabre SA, Laboratory Corp. of America Holdings, Laboratory Corporation of America, Inc., Lupin Atlantis Holdings SA, Lupin Pharmaceuticals, Inc., Lupin, Inc. and Stallergenes Greer, Inc. Mr. Bélingard was previously employed as a Chairman by Fédération Françaises des Industries de Santé, an Independent Director by Stallergenes SA, an Independent Non-Executive Director by Stallergenes Greer Plc, a Chairman & Chief Executive Officer by Ipsen SA, a Managing Director by Mayroy SA, a Chief Executive Officer by Ipsen Pharma SA, a Chief Executive Officer & Director by Biomerieux Pierre Fabre SA, a Managing Director by F. Hoffmann-La Roche Ltd., a Chief Executive Officer by Roche Diagnostics, a Head-Diagnostics Division by Roche Group, and a Senior Director by Merck Sharp & Dohme Corp. He also served on the board at Celera Corp., Tercica, Inc., Institut National de la Santé et de la Recherche Médicale, Nicox SA, ExonHit Therapeutics SA, Applera Corp., Applera Corp., A.E.S. Laboratoire Groupe SA, Advanced BioScience Laboratories, Inc. and AES Chemunex SA. He received his undergraduate degree from École des Hautes Études Commerciales de Paris and an MBA from Cornell University.